Coronavirus strain D614G is ‘better at infecting human cells’ than original version



[ad_1]

A mutated version of the coronavirus, dubbed D614G, is found in 85% of cases worldwide and researchers believe this version is so common because its genetic modification makes it more infectious and better at spreading.

However, an expert analysis from the University of North Carolina found that the change did not make it more deadly or likely to cause severe symptoms.

D614G is by far the most common strain of coronavirus in humans worldwide and first appeared in February in Europe.

International travel allowed this variant to spread across the continent and into the Americas, Oceania, and Asia in a matter of weeks.

Scroll down the video

The D614G mutation is the most common variant of the coronavirus, found in 85% of cases worldwide, and researchers believe this mutant version thrives because its modification made it more infectious and better at spreading

The D614G mutation is the most common variant of the coronavirus, found in 85% of cases worldwide, and researchers believe this mutant version thrives because its modification made it more infectious and better at spreading

In the early days of the Covid-19 pandemic, the dominant form of the virus was a variant now referred to as “D strain”.

However, the D614G mutation appeared at a specific location, position 614, on the virus spike protein, in a European patient.

This viral spike hijacks the human ACE2 receptor and thus infects human cells.

The location of the mutation is at a critical time that affects how the virus divides into two after infiltrating a cell.

The mutation is very small and simple, an amino acid changes from a D (aspartate) to a G (glycine), hence the nickname D614G.

As Italians, Brits and others from coronavirus hotspots traveled to Asia, Australia and America, the D614G virus subsequently took hold in those regions.

Data from a study published last month shows a peak in the G strain in Europe in early February, followed by another resurgence of the G variant fifteen days later.

In early March, cases of D614G were spotted around the world, and this specific mutation accounted for about a quarter of all cases.

It continued to take over and made up more than 70% of all cases in May, and the number is now estimated to exceed 85%.

Scientists tried to determine why the D614G strain emerged as the main form of SARS-CoV-2, the virus that causes Covid-19.

These graphs show the rise of the D614G strain over time.  The blue line and colored area show how common D614G is, as a percentage, among all coronavirus cases on different continents.  The G strain is now by far the most common, replacing the original variant, all over the world

These graphs show the rise of the D614G strain over time. The blue line and colored area show how common D614G is, as a percentage, among all coronavirus cases on different continents. The G strain is now by far the most common, replacing the original variant, all over the world

The orange part of the graph shows the percentage of coronavirus cases that are strain D. Blue shows how common strain G is.  Over time, variant G supplanted strain D

The orange part of the graph shows the percentage of coronavirus cases that are strain D. Blue shows how common strain G is. Over time, variant G supplanted strain D

The latest study, published in the journal Science, created a lab-built version of the mutant virus and observed how it infected mice and hamsters modified to have the human version of the ACE2 receptor.

ACE2 has been dubbed the ‘gateway to the cell’ for the coronavirus and the interaction between it and the viral peak is the focus of much research.

Yixuan Hou, lead author of the study, at the University of North Carolina, says the amount of virus an animal was infected with was similar whether it was strain D or G.

How an amino acid led to a major mutation in SARS-CoV-2

The study by the Royal Society’s Science in Emergencies Tasking – COVID-19 (SET-C) working group also investigated the major mutation in SARS-CoV-2.

It is located on the S protein that protrudes from the surface of the virus.

This peak locks onto the ACE2 receptor in human cells, prompts it to open the cell, and allows the pathogen to infect a person.

At a specific location – residue 614 at the S1 end – the original form of the coronavirus had the amino acid aspartate, marked with a D.

However, a random mutation saw this amino acid replaced by a glycine, marked with a G.

The so-called D614G mutation was seen in almost all samples taken in February.

However, as of March, more than a quarter (26%) of strains isolated of SARS-CoV-2 contained the mutation.

By May, that figure had reached 70%.

The D614G mutation is the most dominant in the world.

This mutation appears to help more viruses infect a person and more efficient infection of cells.

The D614G virus is also almost always accompanied by three other minor mutations. The role of these changes remains unknown.

“However, the D614G variant transmits much faster and has shown better competitive ability than the wild type virus in hamsters.

“These data show that the D614G substitution improves SARS-CoV-2 infectivity, competitiveness, and transmission in primary human cells and animal models.

Hamsters with the mutated strain lost somewhat more weight than those with the original variant but the authors say this is negligible and overall the D614G substitution does not significantly improve the pathogenesis of the virus.

The variant was transmitted much faster in hamsters, which the authors say indicates that the virus evolved not for greater pathogenicity, but for better human transmissibility.

These findings, although not in humans, offer some of the most convincing evidence to date that the mutation spread rapidly due to improved transmissibility.

The researchers also used human cells from gates to see if the mutated strain was more efficient at infecting the cells and found it to be.

The ancestral version and the mutated version were injected into cells and after three days the G strain was extremely dominant in the cultures.

This happened ‘regardless of the fact that [original] virus was at a 1: 1 or 10: 1 ratio to the isogenic mutant D614G, ”the researchers say.

Although the study confirms that the mutation is more infectious, it cannot be determined why.

However, a recent study, published on the medRxiv preprint server and not yet peer-reviewed, from the University of Louvain in Belgium found that the D614G mutation causes the coronavirus to thrive at 37 ° C, human body temperature.

It is more stable at this temperature than the original D strain, which prefers 33 ° C.

This difference makes the new variant more stable at the exact temperatures seen in the human airways.

The mutation is also associated with an increased ability to manipulate proteases, enzymes in cells that destroy proteins, to facilitate infection.

“ Collectively, our results indicate how the coronavirus spike protein is adapted to the temperature and protease conditions of the airways, to improve virus transmission and pathology, ” the academics write.

WHAT IS AN ACE-2 RECEIVER AND WHAT SHOULD IT DO WITH COVID-19?

ACE-2 receptors are structures found on the surface of cells in the lungs and airways that work with an enzyme called ACE (angiotensin converting enzyme) to regulate blood pressure.

Its exact function in the lungs is not well understood, but studies suggest that it protects against lung damage and that low levels of it can worsen the impact of viral infections.

Scientists say the coronavirus that causes COVID-19 enters the body through the ACE-2 receptor, to which its shape allows it to attach.

This means that a person with more ACE-2 receptors may be more sensitive to a large viral load – the first infectious dose of a virus – entering their bloodstream.

People who have a higher number of ACE-2 receptors than usual may include people with diabetes or high blood pressure because they have genetic defects that cause them to produce more.

However, high levels of ACE-2 receptors can also be protective.

They are believed to be able to protect the lungs during infection, and a 2008 mouse study found that mice with ACE-2 blocked in their bodies suffered more damage when infected with the SARS, which is almost identical to COVID-19.

In the past, smoking has been repeatedly associated with lower than normal levels of ACE-2 receptors, potentially increasing the risk of lung damage from COVID-19.

[ad_2]

Source link